Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Once Daily Dose Dexlansoprazole Levofloxacin Based Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Controlled Study

NCT03087162 is registered in ClinicalTrials.gov with Ramathibodi Hospital as lead sponsor.

NCT NCT03087162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03087162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Once Daily Dose Dexlansoprazole Levofloxacin Based Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Controlled Study
Lead sponsor
Ramathibodi Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2017
Completion date
December 1, 2017
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

h pylori eradication